Eye disorder is a ‘very rare’ side effect of weight-loss drugs, concludes EMA review

The eye disorder non-arteritic anterior ischemic optic neuropathy (NAION) is a “very rare side effect” of the use of semaglutide medicines, a review conducted by the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded. In a statement published on 6 June 2025, the PRAC said it had reviewed “all available data on […]